본문으로 건너뛰기
그룹별 보기 기록 1739건 · 페이지 1/35

사용금지 화장품 물질 — 부속서 II

부속서 II는 화장품 원료로 의도적으로 첨가하는 것이 금지된 물질을 나열합니다. 제17조는 별도로, 우수화장품제조관리기준(GMP)과 제3조의 안전 요건에 따라 기술적으로 피할 수 없는 비의도적 미량을 다룹니다. 이 페이지에는 기록 1739건이 있습니다.

이 부속서 필터링

이 부속서의 구성

Annex II is the prohibition list: 1,739 substances that may not be used in cosmetic products in the EU. Article 17 allows for traces that cannot be avoided — it does not allow for adding them.

  • 1,739 prohibited substances, 1,018 of them carrying a CMR classification.
  • Prohibition covers intentional addition; there is no permitted concentration.
  • Article 17 tolerates unintended traces only where they are technically unavoidable under good manufacturing practice and the product remains safe.
  • Absence from Annex II is not permission — most substances appear in no annex at all.

Annex II is the shortest kind of answer the regulation gives. A substance listed here may not be used as a cosmetic ingredient, and there is no concentration at which that changes. Where other annexes set limits and conditions, this one sets none, because there is nothing to condition.

The nuance people look for lives in Article 17 rather than in the annex. It provides that the unintended presence of a small quantity of a prohibited substance is permitted where it is technically unavoidable under good manufacturing practice and the product remains safe under Article 3. That is a provision about impurities and residues — what arrives with a raw material, what forms during manufacture, what migrates from packaging. It is not a tolerance to formulate against, and a deliberate addition at a low level is not covered by it.

Just over a thousand of these entries carry a CMR classification — carcinogenic, mutagenic or toxic for reproduction under the CLP Regulation. That is the route by which most of them arrived: Article 15 prohibits CMR substances in cosmetics, with a narrow derogation procedure that is rarely used, so a CLP classification generally becomes an Annex II entry in due course.

The most common misreading is the opposite of the list's own logic. A substance not found in Annex II has not been assessed and permitted. It has not been assessed at all. Most cosmetic ingredients appear in no annex, and their acceptability rests on the safety assessment the responsible person is required to hold.

대조 대상

부속서 II 기록

1739 총
이 목록의 기록, 총 1739건
항목물질CAS최대 농도표시
1N-(5-Chlorobenzoxazol-2-yl)acetamideCAS 35783-57-4 35783-57-4 —
2(2-Acetoxyethyl)trimethylammonium hydroxide (Acetylcholine) and its saltsCAS 51-84-3 51-84-3 —
3Deanol aceglumate (INN)CAS 3342-61-8 3342-61-8 —
4Spironolactone (INN)CAS 52-01-7 52-01-7 —
5[4-(4-Hydroxy-3-iodophenoxy)-3,5-diiodophenyl]acetic acid (Tiratricol (INN)) and its saltsCAS 51-24-1 51-24-1 —
6Methotrexate (INN)CAS 59-05-2 59-05-2 —
7Aminocaproic acid (INN) and its saltsCAS 60-32-2 60-32-2 —
8Cinchophen (INN), its salts, derivatives and salts of these derivativesCAS 132-60-5 / 5949-18-8 132-60-5 / 5949-18-8 —
9Thyropropic acid (INN) and its saltsCAS 51-26-3 51-26-3 —
10Trichloroacetic acidCAS 76-03-9 76-03-9 —
11Aconitum napellus L. (leaves, roots and galenical preparations)CAS 84603-50-9 84603-50-9 —
12Aconitine (principal alkaloid of Aconitum napellus L.) and its saltsCAS 302-27-2 302-27-2 —
13Adonis vernalis L. and its preparationsCAS 84649-73-0 84649-73-0 —
14Epinephrine (INN)CAS 51-43-4 51-43-4 —
15Rauwolfia serpentia L., alkaloids and their saltsCAS 90106-13-1 90106-13-1 —
16Alkyne alcohols, their esters, ethers and salts——
17Isoprenaline (INN)CAS 7683-59-2 7683-59-2 —
18Allyl isothiocyanateCAS 57-06-7 57-06-7 —
19Alloclamide (INN) and its saltsCAS 5486-77-1 5486-77-1 —
20Nalorphine (INN), its salts and ethersCAS 62-67-9 62-67-9 —
21Sympathicomimetic amines acting on the central nervous system: any substance contained in the first list of medicaments which are subject to medical prescription and referred to in Resolution AP (69) 2 of the Council of EuropeCAS 300-62-9 300-62-9 —
22Aniline, its salts and its halogenated and sulphonated derivativesCAS 62-53-3 62-53-3 —CMR
23Betoxycaine (INN) and its saltsCAS 3818-62-0 3818-62-0 —
24Zoxazolamine (INN)CAS 61-80-3 61-80-3 —
25Procainamide (INN), its salts and derivativesCAS 51-06-9 51-06-9 —
26BenzidineCAS 92-87-5 92-87-5 —CMR
27Tuaminoheptane (INN), its isomers and saltsCAS 123-82-0 123-82-0 —
28Octodrine (INN) and its saltsCAS 543-82-8 543-82-8 —
292-Amino-1,2-bis(4-methoxyphenyl)ethanol and its saltsCAS 530-34-7 530-34-7 —
301,3-Dimethylpentylamine and its saltsCAS 105-41-9 105-41-9 —
314-Aminosalicylic acid and its saltsCAS 65-49-6 65-49-6 —
32Toluidines, their isomers, salts and halogenated and sulphonated derivativesCAS 26915-12-8 26915-12-8 —
33Xylidines, their isomers, salts and halogenated and sulphonated derivativesCAS 1300-73-8 1300-73-8 —
34Imperatorin (9-(3-methylbut-2-enyloxy)furo[3,2-g]chromen-7-one)CAS 482-44-0 482-44-0 —
35Ammi majus L. and its galenical preparationsCAS 90320-46-0 90320-46-0 —
362,3-Dichloro-2-methylbutaneCAS 507-45-9 507-45-9 —
37Substances with androgenic effect——
38Anthracene oilCAS 120-12-7 120-12-7 —CMR
38Distillates (coal tar), pitch, pyrene fractionCAS 91995-52-7 91995-52-7 —CMR
38Distillates (coal tar), pitchCAS 101316-49-8 101316-49-8 —CMR
39Antibiotics——
40Antimony and its compoundCAS 7440-36-0 7440-36-0 —
41Apocynum cannabium L. and its preparationsCAS 84603-51-0 84603-51-0 —
42Apomorphine ((R)-5,6,6a,7-tetrahydro-6-methyl-4H-dibenzo[de,g]quinoline-10,11-diol)) and its saltsCAS 58-00-4 58-00-4 —
43Arsenic and its compoundsCAS 7440-38-2 7440-38-2 —
44Atropa belladonna L. and its preparationsCAS 8007-93-0 8007-93-0 —
45Atropine, its salts and derivativesCAS 51-55-8 51-55-8 —
46Barium salts, with the exception of barium sulphide under the conditions laid down in Annex III and of barium sulfate, lakes, salts and pigments prepared from the colouring agents when listed in Annex IV——
47BenzeneCAS 71-43-2 71-43-2 —CMR
48Benzimidazol-2(3H)-oneCAS 615-16-7 615-16-7 —

이 그룹별 보기 사용 방법

부속서 II에는 화장품에 사용이 금지된 물질이 포함되어 있습니다. 사용금지 물질 기록 1739건을 명칭, 식별자 및 연결된 항목 페이지별로 빠르게 훑어보려면 이 그룹별 보기를 이용하세요.

법적 문구 전문, 농도 논리, 경고 문구 또는 관련 식별자 링크가 필요하면 개별 기록을 여세요.